Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00687882 · ClinicalTrials.gov registry record · Phase 3
Evaluation of the Duration of Therapy for Thrombosis in Children
A Phase 3 study, sponsored by Johns Hopkins All Children's Hospital.
- Completed
- Registry status
- Phase 3
- Development phase
- 532
- Enrollment target
NCT00687882 is a Phase 3 study that has completed, run by Johns Hopkins All Children's Hospital. The registered enrollment target is 532 participants.
The verdict
NCT00687882, a Phase 3 study, has completed, sponsored by Johns Hopkins All Children's Hospital.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 532 participants
- Enrollment target
Study Summary
The Kids-DOTT trial is a randomized controlled clinical trial whose primary objective is to evaluate non-inferiority of shortened-duration (6 weeks) versus conventional-duration (3 months) anticoagulation in children with first-episode acute venous thrombosis. The first stage of the trial has consisted of a pilot/feasibility component, which then continues as the definitively-powered trial.
Interventions
- OTHER No Intervention
- OTHER Shortened duration (6 weeks) of anticoagulant therapy
- OTHER Conventional duration (3 months) of anticoagulant therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 532 participants |
| Start Date | 2008-03 |
| Est. Completion | 2022-02-15 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00687882
The ClinicalTrials.gov registry entry for NCT00687882 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 532 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins All Children's Hospital, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which No Intervention is the first listed.
NCT00687882 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00687882 about?
NCT00687882 is a clinical study titled "Evaluation of the Duration of Therapy for Thrombosis in Children". The Kids-DOTT trial is a randomized controlled clinical trial whose primary objective is to evaluate non-inferiority of shortened-duration (6 weeks) versus conventional-duration (3 months) anticoagulation in children with first-episode acute venous thrombosis. The first stage of the trial has consis...
What is the current status of trial NCT00687882?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 532 participants. The study started on 2008-03. Estimated completion is 2022-02-15.
What interventions are being tested in trial NCT00687882?
The interventions under investigation include: No Intervention (OTHER), Shortened duration (6 weeks) of anticoagulant therapy (OTHER), Conventional duration (3 months) of anticoagulant therapy (OTHER).
Who is sponsoring clinical trial NCT00687882?
This trial is sponsored by Johns Hopkins All Children's Hospital, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.